Dianthus Therapeutics DNTH
NASDAQ DNTH
$108.10 +0.25 (+0.23%)
As of: Sep 4, 2026 · 3:59 PM EDT

Dianthus Therapeutics (DNTH) Amortizatization of Intangibles (2022 - 2025)

Dianthus Therapeutics (DNTH) posted quarterly Amortizatization of Intangibles of $2.3 million for Q3 2025, down 1.28% year-over-year from $2.3 million in Q3 2024, and up 110.47% quarter-over-quarter from $1.1 million in Q2 2025.

Analysis

Dianthus Therapeutics (DNTH) Amortizatization of Intangibles (2022 - 2025) Analysis & Trends

Dianthus Therapeutics' Amortizatization of Intangibles history runs 4 years deep, the most recent figure standing at $2.3 million for Q3 2025.

  • In Q3 2025, Amortizatization of Intangibles fell 1.28% year-over-year to $2.3 million; the TTM figure through Sep 2025 stood at $8.0 million (up 111.27% YoY), while the FY2024 annual figure was $6.0 million, up 322.91% from the prior year.
  • Amortizatization of Intangibles for Q3 2025 stood at $2.3 million, up from $1.1 million in the prior quarter.
  • The five-year high for Amortizatization of Intangibles was $2.7 million in Q4 2024, with the low at $208000.0 in Q2 2023.
  • The 4-year median for Amortizatization of Intangibles is $522500.0 (2023), against an average of $1.1 million.
  • The sharpest annual moves came in 2024 and 2025: Amortizatization of Intangibles surged 609.39% in 2024, then dropped 1.28% in 2025.
  • Dianthus Therapeutics' Amortizatization of Intangibles stood at $402000.0 in 2022, then soared by 31.09% to $527000.0 in 2023, then soared by 419.35% to $2.7 million in 2024, then declined by 15.56% to $2.3 million in 2025.
  • Business Quant data shows DNTH's Amortizatization of Intangibles at $2.3 million in Q3 2025, $1.1 million in Q2 2025, and $1.9 million in Q1 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -
5 Revolution Medicines 44.33 Bn 44.33 Bn - 4.33 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn -
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 678,000.00
10 Dianthus Therapeutics 4.09 Bn 3.69 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 2.31 Mn
Jun 30, 2025 1.10 Mn
Mar 31, 2025 1.90 Mn
Dec 31, 2024 2.74 Mn
Sep 30, 2024 2.34 Mn
Jun 30, 2024 422,000.00
Mar 31, 2024 518,000.00
Dec 31, 2023 527,000.00
Sep 30, 2023 330,000.00
Jun 30, 2023 208,000.00
Mar 31, 2023 358,000.00
Dec 31, 2022 402,000.00
Mar 31, 2022 699,000.00